Description
Overview
Mitochondria-targeting tetrapeptides can penetrate cell membranes and accumulate in the inner mitochondrial membrane. Protects cardiolipin (key mitochondrial phospholipid) from oxidative damage.
| Chemical Class | Mitochondria targeting peptides |
| Dosage Form | Lyophilized powder |
| Specification | In clinical phase II trial |
| Storage | Refrigerate at 2-8°C |
Mechanism of Action
- Cardiolipin protection: maintaining mitochondrial inner membrane structure and function
- ROS reduction: reduces mitochondrial reactive oxygen species production
- ATP synthesis protection: maintaining mitochondrial energy production efficiency
- Apoptosis Inhibition: Reducing Cell Death by Mitochondrial Pathways
- Related Indications: Cell protection at the mitochondrial level, delaying aging-related energy decline.
| Indication | Mechanism | Evidence |
|---|---|---|
| Mitochondrial function maintenance | cardiolipin protection | Clinical Phase II |
| Myocardial protection | Heart mitochondria enrichment | clinical exploration |
| Muscle function maintenance | Skeletal muscle mitochondrial protection | clinical exploration |
| Age-related changes in the eyes | Retinal mitochondrial protection | clinical exploration |
Dosage & Administration
- Data source: Based on ClinicalTrials.gov public trial protocol/approved instructions
Safety Information
- Data source: Based on PubMed safety research literature
Regulatory Status
Drug Interactions
- Data source: Derivation based on mechanism of action + PubMed literature
FAQ
Disclaimer: This product is intended for research purposes only. Not for human consumption or therapeutic use. These statements have not been evaluated by the FDA. This product is not intended to diagnose, treat, cure, or prevent any disease.





Reviews
There are no reviews yet.